Gemina Laboratories Ltd.
GLAB.CNCNQHealthcare
$0.06
+$0.00(+0.00%)
Market Cap$4594254
P/E Ratio—
52W High$1.25
52W Low$0.05
Gemina Laboratories Ltd. (GLAB.CN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GLAB.CN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-01 | 2024-01 | 2023-01 | 2022-01 | 2021-01 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | ($0.00B) | $0.00B | ($0.00B) |
| Net Income | ($0.00B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.06 | $-0.07 | $-0.10 | $-0.10 | $-0.02 |
| Wtd Avg Shares | 0.07B | 0.07B | 0.06B | 0.05B | 0.05B |
| EBITDA | ($0.00B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · B
Explore more Gemina Laboratories Ltd. data
About Gemina Laboratories Ltd. (GLAB.CN) Income Statement
Gemina Laboratories Ltd. (GLAB.CN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GLAB.CN reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.00B) — a net profit margin of —.
Frequently asked questions
GLAB.CN · 4 questionsGemina Laboratories Ltd. (GLAB.CN) reported revenue of $0.00B for 2025, down —% year-over-year.
GLAB.CN revenueGLAB.CN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08